Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between SLCO1B1 and statins and CYP2C9 and sulfonylureas
David F.G.J. Wolthuis, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer‐Veger, Anne M. Buunk, Henk‐Jan Guchelaar, Arne Risselada, Gerard A. Rongen, Ron H. N. van Schaik, Jesse J. Swen, Daan J. Touw, Roos van Westrhenen, Vera H.M. Deneer, Elisa J. F. Houwink
Topics & Concepts
SLCO1B1RosuvastatinPharmacogeneticsPharmacologyCYP2C9MedicineFluvastatinAtorvastatinStatinTolbutamideSulfonylureaGlimepirideGuidelineInternal medicineBiologySimvastatinGeneticsGeneInsulinGenotypeMetforminCytochrome P450PathologyMetabolismPharmacogenetics and Drug MetabolismLipoproteins and Cardiovascular HealthHealth Systems, Economic Evaluations, Quality of Life